YSB Inc.

Founded in 2015, YSB Inc. (the “Company”or“YSB”) is the largest digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors,vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream in a safe and efficient way, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. With the mission of building a safer and more efficient trading and service platform for the pharmaceutical industry, YSB drives the improvement of the overall efficiency of the medical and health ecosystem. Through deep cultivation of the grassroots market, YSB has accumulated strong data ability, built and continuously improved the business model, in order to meet the increasing digital demand of the out-of-hospital pharmaceutical market. According to Frost & Sullivan, the total GMV of YSB Inc. has reached RMB37.8 billion in 2022, representing a CAGR of 38.6% from that in 2020, both the highest among leading digital pharmaceutical platforms serving businesses outside of hospitals in China. At the same time, we has covered 379,000 pharmacies and 211,000 primary healthcare institutions, among which the average monthly active buyers reach 353,000, establishing the largest digital pharmaceutical trading and service network in China.